Rankings
▼
Calendar
IONS Q1 2024 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$13B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$119M
-8.4% YoY
Gross Profit
$117M
98.2% margin
Operating Income
-$150M
-125.1% margin
Net Income
-$143M
-119.5% margin
EPS (Diluted)
$-0.98
QoQ Revenue Growth
-63.2%
Cash Flow
Operating Cash Flow
-$150M
Free Cash Flow
-$156M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$2.8B
Total Liabilities
$2.5B
Stockholders' Equity
$297M
Cash & Equivalents
$349M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$119M
$131M
-8.4%
Gross Profit
$117M
$129M
-9.2%
Operating Income
-$150M
-$114M
-31.0%
Net Income
-$143M
-$124M
-14.9%
← FY 2024
All Quarters
Q2 2024 →